| Heart Failure Therapy and Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction (NCT06671314) | Novartis | 2022-06-02 |
| Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy (NCT05795400) | National Medical Research Center for Cardiology, Ministry of Health of Russian Federation | 2022-06-01 |
| Effectiveness of CRD-740 in Heart Failure (NCT05409183) | Cardurion Pharmaceuticals, Inc. | 2022-05-26 |
| Exercise Capacity Before and After AF Ablation in Patients With HFpEF (NCT05376748) | University of Vermont | 2022-04-15 |
| Selective PDE9 Inhibition With IMR-687 in Adults With Heart Failure With Preserved Ejection Fraction (NCT05312021) | Cardurion Pharmaceuticals, Inc. | 2022-04-01 |
| The Effect of a High Fiber Diet and High-Intensity Interval Exercise in Patients With HFpEF (NCT05236413) | University of Virginia | 2022-04-01 |
| HEART Camp Connect: A Feasibility Study (NCT05985395) | University of Nebraska | 2022-03-28 |
| NMES in HF Patients to Improve Functional Recovery Following Hospitalization (NCT05338437) | University of Vermont Medical Center | 2022-02-07 |
| Assessment of CCM in HF With Higher Ejection Fraction (NCT05064709) | Impulse Dynamics | 2022-02-03 |
| Sex Related Differences in Cardiac Function (NCT05796050) | Heinrich-Heine University, Duesseldorf | 2022-02-02 |
| Modulation of Circulating Levels of the Ketone Body 3-hydroxybutyrate in Patients With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction: Cardiovascular Effects. (NCT05236335) | University of Aarhus | 2022-02-01 |
| PErirenal Adipose Tissue and RenaL Hemodynamics in Patients With Heart Failure With Preserved Ejection Fraction (NCT05219188) | University Medical Center Groningen | 2022-02-01 |
| Optimising CMR Scan Acquisitions for Novel Equipment/Sequences in Clinical Cardiovascular Populations. (NCT06311552) | University of Leicester | 2022-01-31 |
| WeighT LOSS Surgery and Comprehensive Cardiometabolic Responses to to EXercise (NCT06576050) | Massachusetts General Hospital | 2022-01-25 |
| SGLT2i and KNO3 in HFpEF - The SAK HFpEF Trial (NCT05138575) | University of Pennsylvania | 2022-01-24 |
| Metformin for Older Patients With Heart Failure With Preserved Ejection Fraction (NCT05093959) | Wake Forest University Health Sciences | 2022-01-04 |
| Heart Failure With Preserved Ejection Fraction: Evaluation and Recognition by CMR (NCT05114785) | University of East Anglia | 2022-01-01 |
| Beta-blocker Discontinuation in Heart Failure With Preserved Ejection Fraction (NCT05174351) | UConn Health | 2021-12-20 |
| Randomized Controlled Pilot Trial of DASH Feeding in Older Low Socioeconomic Adults Without Heart Failure (NCT04113291) | Wake Forest University Health Sciences | 2021-12-01 |
| Extended IASD Investigation: REDUCE LAP-HF IV (NCT04632160) | Corvia Medical | 2021-12-01 |
| Renal Denervation to Treat Heart Failure With Preserved Ejection Fraction (NCT05030987) | University of Leipzig | 2021-11-30 |
| Impact of Intravenous Iron Repletion On Mechanisms of Exercise InTolerance in HFpEF (IRONMET-HFpEF) (NCT04945707) | Massachusetts General Hospital | 2021-11-26 |
| Efficacy of an m-Health Cardiac Rehabilitation Program in Heart Failure With Preserved Ejection Fraction (NCT05002075) | University of Texas Southwestern Medical Center | 2021-11-20 |
| Carvedilol in HF With Preserved EF (NCT05553314) | Seoul National University Bundang Hospital | 2021-11-17 |
| Impact of Empagliflozin on Functional Capacity in Heart Failure with Preserved Ejection Fraction (NCT05139472) | University of Texas Southwestern Medical Center | 2021-11-09 |
| The Effect of Angiotensin Receptor-Neprilysin Inhibition on Cardiac Fibrosis in Patients With HFpEF (NCT05089539) | Chongqing Medical University | 2021-11-01 |
| Exercise Right Ventricular Coupling in HFpEF (NCT05731466) | Universitaire Ziekenhuizen KU Leuven | 2021-10-13 |
| Matching Perfusion and Metabolic Activity in HFpEF (NCT04913805) | University of Pennsylvania | 2021-10-11 |
| The Relationship Between Heart Function and Metabolism in HFpEF Patients (NCT05053256) | Chongqing Medical University | 2021-10-01 |
| A Single-center Retrospective Cohort Study to Explore the Prognostic Significance of CONUT in Elderly CAD Patients With HFpEFand Compare CONUT With Other Objective Nutritional Indices. (NCT05586828) | Beijing Tongren Hospital | 2021-09-01 |
| Cilostazol for HFpEF (NCT05126836) | University of Minnesota | 2021-09-01 |
| PeRsonalIzed remOtely Guided Preventive exeRcIse Therapy for a healThY Heart (NCT04745013) | KU Leuven | 2021-09-01 |
| Diastolic Exercise Stress Testing in Heart Failure (NCT04970953) | University Hospital, Essen | 2021-08-09 |
| HFpEF and Symptomatic Obstructive Iliofemoral Venous Disease Study (NCT04964817) | Prairie Education and Research Cooperative | 2021-08-03 |
| Study to Evaluate the Efficacy and Safety of AZD4831 in Participants With Heart Failure With Left Ventricular Ejection Fraction > 40% (NCT04986202) | AstraZeneca | 2021-06-30 |
| Novel Approaches for Improving Vascular Function in Veterans With HFpEF (NCT06312748) | VA Office of Research and Development | 2021-05-19 |
| Gut Microbiota in Chronic Noncommunicable Diseases (NCT04820556) | National Medical Research Center for Therapy and Preventive Medicine | 2021-04-12 |
| Impact of Beta-blockers on Physical Function in HFpEF (NCT04767061) | Weill Medical College of Cornell University | 2021-04-01 |
| CMR T1 Mapping for Diagnosis of Cardiac Amyloidosis (NCT04862273) | University of Leipzig | 2021-04-01 |
| Pilot Deprescribing N-of-1 Trials for Beta-blockers in HFpEF (NCT04757584) | Weill Medical College of Cornell University | 2021-04-01 |
| A Study of Mavacamten in Participants With HFpEF and Elevation of NT-proBNP With or Without Elevation of cTnT (NCT04766892) | Bristol-Myers Squibb | 2021-03-30 |
| Incidence and Echocardiographic Predictors of HFpEF in High-Risk Population Afferent to Italian Echo-labs Network (NCT05753553) | IRCCS Policlinico S. Donato | 2021-03-02 |
| Wearable Remote Monitoring of Heart Rate and Respiratory Rate for Heart Failure (NCT04455828) | Milton S. Hershey Medical Center | 2021-03-01 |
| Dapagliflozin (DAPA) Effects in HFpEF (NCT04730947) | Mayo Clinic | 2021-02-24 |
| Distribution and Clinical Implication of CMD in Patients With HFpEF Without Significant CAD (NCT04788576) | Samsung Medical Center | 2021-01-25 |
| Radiofrequency (RF) Ablation for Atrial Fibrillation (AF) in Patients With Heart Failure With Preserved Ejection Fraction (NCT04327596) | University of Rochester | 2021-01-25 |
| Effort-Lung Ultra Sound (NCT04644692) | Central Hospital, Nancy, France | 2021-01-18 |
| Global Prevalence of ATTR-CM in Participants With HFpEF (NCT04424914) | Pfizer | 2020-12-30 |
| Phenotypes and Outcomes of Heart Failure With Preserved Ejection Fraction in Patients With Hypertension and Diabetes (NCT04835194) | University of Medicine and Pharmacy at Ho Chi Minh City | 2020-12-01 |
| Study to Evaluate Sex Differences in the Acute Effects of PL-3994 in Heart Failure Subjects (NCT04318145) | Palatin Technologies, Inc | 2020-11-12 |
| The Relationship Between Epicardial Fat Tissue and Cardiac Function in HFpEF Patients (NCT05068934) | Dongying Zhang | 2020-10-12 |
| Relationship Between Ambulatory Arterial Stiffness Index and Left Ventricular Diastolic Function in Patients With HFpEF (NCT05059769) | Dongying Zhang | 2020-10-10 |
| Acute Effects of Exogenous Ketone Ester Administration in Heart Failure (NCT04633460) | University of Pennsylvania | 2020-10-06 |
| Effect of Bilirubin on Prognosis in Heart Failure With Preserved Ejection Fraction (NCT06379152) | Chongqing Medical University | 2020-09-20 |
| The ENCHANTMENT HIV Study (NCT04153136) | Massachusetts General Hospital | 2020-09-11 |
| The Relationship Between Pericardial Fat Thickness and Arterial Stiffness in HFpEF Patients (NCT04594499) | Chongqing Medical University | 2020-09-01 |
| Follow Up of acuTe Heart failUre: a pRospective Echocardiographic and Clinical Study (FUTURE) (NCT05204238) | University of Siena | 2020-09-01 |
| The Relationship Between Blood Pressure and Arterial Stiffness in HFpEF Patients With Different Levels of Obesity (NCT04535726) | Chongqing Medical University | 2020-09-01 |
| Heart Failure Monitoring With Eko Electronic Stethoscopes (NCT04404452) | Eko Devices, Inc. | 2020-07-06 |
| Balance, Aerobic Capacity, Mobility and Strength in Patients Hospitalized for Heart Failure (BAMS-HF) Program (NCT04281849) | VA Eastern Colorado Health Care System | 2020-06-15 |
| Transcutaneous Vagus Nerve Stimulation in Heart Failure (NCT05789147) | Istituti Clinici Scientifici Maugeri SpA | 2020-06-15 |
| The Efficacy and Safety of Zhigancao Tang Granule for HFpEF of Qi-Yin Dificiency (NCT04317339) | Shanghai University of Traditional Chinese Medicine | 2020-03-20 |
| The Prognostic Role and Diagnostic Efficacy of Exercise Right Heart Catheterization With a Simultaneous Echocardiography in Patients With Dyspnea on Exertion (NCT05490901) | Samsung Medical Center | 2020-03-17 |
| Developing Oral LT3 Therapy for Heart Failure - HFpEF (NCT04111536) | University of Pennsylvania | 2020-03-08 |
| Heart Failure and Preserved Ejection Fraction: Observation of Its Progression and Prognosis (HOPP-BERN) (NCT04395846) | Insel Gruppe AG, University Hospital Bern | 2020-03-02 |
| Study of the Prognosis of Patients With Heart Failure With Preserved Ejection Fraction (NCT05496439) | Chongqing Medical University | 2020-03-01 |
| 3-Month Home-based Training With Whole Body Vibration (WBV) Device in Patients With Heart Failure and Preserved Ejection Fraction (GALILEO-HFpEF-HOME) (GALILEOHOME) (NCT04239807) | Klinikum der Universität Köln | 2020-03-01 |
| Ambulatory Blood Pressure in HFPEF Outcomes Global Registry (NCT04065620) | Hospital Clinic of Barcelona | 2020-03-01 |
| Retrospective Observational Analysis of a Cohort With Heart Failure With Preserved Ejection Fraction (NCT04233086) | Portsmouth Hospitals NHS Trust | 2020-02-03 |
| Study of Sacubitril/ValsarTan on MyocardIal OxygenatioN and Fibrosis in Heart Failure With Preserved Ejection Fraction (NCT04128891) | Flinders University | 2020-02-01 |
| Endovascular GSN Ablation in Subjects With HFpEF (NCT04287946) | Axon Therapies, Inc. | 2020-02-01 |
| Heart Failure in Norway: Clinical Characteristics, Mortality and Health Care Resource Use (NCT04398563) | University Hospital, Akershus | 2020-01-20 |
| Association of Epicardial Adipose Tissue Volume Axnd Radiodensity With Coronary Artery Calcification in Patients With HFpEF (NCT05556785) | Chongqing Medical University | 2020-01-01 |
| Ketogenic Diet in Patients With Heart Failure (NCT04235699) | Ohio State University | 2019-12-22 |
| Invasive Left Heart Catheterization Registry (NCT04505449) | Samsung Medical Center | 2019-12-13 |
| PACIFIC-PRESERVED : PhenomApping, ClassIFication, and Innovation for Cardiac Dysfunction - HF With PRESERVED LVEF Study (NCT04189029) | Assistance Publique - Hôpitaux de Paris | 2019-12-09 |
| Assessment of Pulmonary Congestion During Cardiac Hemodynamic Stress Testing (NCT04019613) | Mayo Clinic | 2019-11-08 |
| Adipose Tissue Inflammation in HFpEF (NCT04886713) | Heart Center Leipzig - University Hospital | 2019-11-01 |
| Real-Time Monitoring of Heart Failure Across the Yale New Haven Health System (NCT04237701) | Yale University | 2019-10-01 |
| Cardiac Amyloidosis in HFpEF (NCT04587648) | National Taiwan University Hospital | 2019-08-01 |
| Virtual Visits to Optimize Research Trial Offerings to HF Patients (NCT04064541) | The Cleveland Clinic | 2019-08-01 |
| Chronic Kidney Disease and Heart Failure With Preserved Ejection Fraction: The Role of Mitochondrial Dysfunction (NCT03960073) | Virginia Commonwealth University | 2019-07-31 |
| Purinergic Signaling and the Postmenopausal Heart (NCT06015776) | Beth Israel Deaconess Medical Center | 2019-07-01 |
| Pressure Assessment to Improve Outcomes After TAVR: a Registry (NCT03923530) | North Florida Foundation for Research and Education | 2019-06-03 |
| Evaluation of Renal Sodium Excretion After Salt Loading in Heart Failure With Preserved Ejection Fraction (NCT03837470) | Adhish Agarwal | 2019-05-06 |
| Carvedilol SR Study for Biomarkers From Blood and Urine and Safety of in Patients With Heart Failure With Preserved Ejection Fraction (NCT03948685) | Yonsei University | 2019-05-01 |
| Neuregulin-1 in Patient With Different Forms of Cardiovascular Diseases: a Pilot Study (NCT04391491) | I.M. Sechenov First Moscow State Medical University | 2019-03-01 |
| Prediction of the Development of Heart Failure With Preserved Ejection Fraction (NCT04894968) | Heart Center Leipzig - University Hospital | 2018-12-01 |
| Spironolactone in the Treatment of Heart Failure (NCT04727073) | Charite University, Berlin, Germany | 2018-11-01 |
| Exploration of Dyspnea at Non-high Brain Natriuretic Peptide (BNP) (NCT03550235) | Assistance Publique - Hôpitaux de Paris | 2018-10-08 |
| Right Ventricular Function and Pulmonary Hypertension in HFpEF (NCT05055180) | Heart Center Leipzig - University Hospital | 2018-10-01 |
| Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure. (NCT03619213) | AstraZeneca | 2018-08-27 |
| Circulating NEP and NEP Inhibition Study in Heart Failure With Preserved Ejection Fraction (NCT03506412) | Mayo Clinic | 2018-06-25 |
| Understanding the Mechanisms of Diastolic Dysfunction (NCT03340233) | University of California, Los Angeles | 2018-06-01 |
| Cardiac Magnetic Resonance Assessment for Heart Failure With Preserved Ejection Fraction (NCT04063579) | The University of Hong Kong | 2018-06-01 |
| Frequency and Magnitude of Subclinical Systolic Dysfunction by Strain Imaging in Heart Failure With Preserved Ejection Fraction (NCT04163861) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2018-05-05 |
| UTSW HP [13-C] Pyruvate Injection in HCM (NCT03057002) | University of Texas Southwestern Medical Center | 2018-05-01 |
| Transthyretin Cardiac Amyloidosis in HFpEF (NCT03414632) | Mayo Clinic | 2017-12-01 |
| Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction (NCT02901184) | Uppsala University | 2017-11-23 |
| A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) (NCT03254485) | Akebia Therapeutics | 2017-11-07 |